vs

Side-by-side financial comparison of Evolus, Inc. (EOLS) and TSS, Inc. (TSSI). Click either name above to swap in a different company.

Evolus, Inc. is the larger business by last-quarter revenue ($73.1M vs $60.9M, roughly 1.2× TSS, Inc.). TSS, Inc. runs the higher net margin — 20.0% vs -14.6%, a 34.6% gap on every dollar of revenue. On growth, TSS, Inc. posted the faster year-over-year revenue change (21.8% vs 6.7%). Over the past eight quarters, TSS, Inc.'s revenue compounded faster (95.8% CAGR vs 4.6%).

Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.

EOLS vs TSSI — Head-to-Head

Bigger by revenue
EOLS
EOLS
1.2× larger
EOLS
$73.1M
$60.9M
TSSI
Growing faster (revenue YoY)
TSSI
TSSI
+15.0% gap
TSSI
21.8%
6.7%
EOLS
Higher net margin
TSSI
TSSI
34.6% more per $
TSSI
20.0%
-14.6%
EOLS
Faster 2-yr revenue CAGR
TSSI
TSSI
Annualised
TSSI
95.8%
4.6%
EOLS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EOLS
EOLS
TSSI
TSSI
Revenue
$73.1M
$60.9M
Net Profit
$-10.7M
$12.2M
Gross Margin
66.9%
17.6%
Operating Margin
23.8%
1.5%
Net Margin
-14.6%
20.0%
Revenue YoY
6.7%
21.8%
Net Profit YoY
535.7%
EPS (diluted)
$-0.16
$0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EOLS
EOLS
TSSI
TSSI
Q1 26
$73.1M
Q4 25
$90.3M
$60.9M
Q3 25
$69.0M
$41.9M
Q2 25
$69.4M
$44.0M
Q1 25
$68.5M
$99.0M
Q4 24
$78.9M
$50.0M
Q3 24
$61.1M
$70.1M
Q2 24
$66.9M
$12.2M
Net Profit
EOLS
EOLS
TSSI
TSSI
Q1 26
$-10.7M
Q4 25
$130.0K
$12.2M
Q3 25
$-15.7M
$-1.5M
Q2 25
$-17.1M
$1.5M
Q1 25
$-18.9M
$3.0M
Q4 24
$-6.8M
$1.9M
Q3 24
$-19.2M
$2.6M
Q2 24
$-11.3M
$1.4M
Gross Margin
EOLS
EOLS
TSSI
TSSI
Q1 26
66.9%
Q4 25
65.7%
17.6%
Q3 25
66.5%
11.1%
Q2 25
65.3%
17.8%
Q1 25
68.1%
9.3%
Q4 24
66.7%
14.4%
Q3 24
68.9%
11.3%
Q2 24
70.3%
37.3%
Operating Margin
EOLS
EOLS
TSSI
TSSI
Q1 26
23.8%
Q4 25
4.7%
1.5%
Q3 25
-16.7%
-2.2%
Q2 25
-14.7%
5.1%
Q1 25
-22.1%
4.2%
Q4 24
-2.9%
0.0%
Q3 24
-25.3%
5.4%
Q2 24
-11.5%
14.0%
Net Margin
EOLS
EOLS
TSSI
TSSI
Q1 26
-14.6%
Q4 25
0.1%
20.0%
Q3 25
-22.8%
-3.6%
Q2 25
-24.7%
3.4%
Q1 25
-27.6%
3.0%
Q4 24
-8.6%
3.8%
Q3 24
-31.4%
3.8%
Q2 24
-17.0%
11.5%
EPS (diluted)
EOLS
EOLS
TSSI
TSSI
Q1 26
$-0.16
Q4 25
$0.01
$0.44
Q3 25
$-0.24
$-0.06
Q2 25
$-0.27
$0.06
Q1 25
$-0.30
$0.12
Q4 24
$-0.11
$0.08
Q3 24
$-0.30
$0.10
Q2 24
$-0.18
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EOLS
EOLS
TSSI
TSSI
Cash + ST InvestmentsLiquidity on hand
$49.8M
$85.5M
Total DebtLower is stronger
$156.4M
Stockholders' EquityBook value
$76.6M
Total Assets
$220.6M
$184.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EOLS
EOLS
TSSI
TSSI
Q1 26
$49.8M
Q4 25
$53.8M
$85.5M
Q3 25
$43.5M
$70.7M
Q2 25
$61.7M
Q1 25
$67.9M
Q4 24
$87.0M
$23.2M
Q3 24
$85.0M
$46.4M
Q2 24
$93.7M
$8.3M
Total Debt
EOLS
EOLS
TSSI
TSSI
Q1 26
$156.4M
Q4 25
$146.1M
Q3 25
Q2 25
Q1 25
$121.8M
Q4 24
$121.5M
Q3 24
$121.2M
Q2 24
$120.9M
Stockholders' Equity
EOLS
EOLS
TSSI
TSSI
Q1 26
Q4 25
$-23.1M
$76.6M
Q3 25
$-28.8M
$63.4M
Q2 25
$-18.7M
$9.5M
Q1 25
$-6.6M
$9.4M
Q4 24
$5.5M
$7.1M
Q3 24
$5.9M
$7.7M
Q2 24
$19.3M
$5.2M
Total Assets
EOLS
EOLS
TSSI
TSSI
Q1 26
$220.6M
Q4 25
$225.9M
$184.9M
Q3 25
$219.0M
$165.4M
Q2 25
$228.8M
$139.5M
Q1 25
$213.4M
$113.5M
Q4 24
$232.6M
$96.6M
Q3 24
$229.6M
$67.3M
Q2 24
$233.8M
$28.9M
Debt / Equity
EOLS
EOLS
TSSI
TSSI
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
22.00×
Q3 24
20.58×
Q2 24
6.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EOLS
EOLS
TSSI
TSSI
Operating Cash FlowLast quarter
$16.3M
Free Cash FlowOCF − Capex
$15.8M
FCF MarginFCF / Revenue
25.9%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
1.34×
TTM Free Cash FlowTrailing 4 quarters
$2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EOLS
EOLS
TSSI
TSSI
Q1 26
Q4 25
$12.8M
$16.3M
Q3 25
$-14.7M
$-18.4M
Q2 25
$-24.8M
$16.3M
Q1 25
$-15.6M
$20.6M
Q4 24
$4.8M
$-21.6M
Q3 24
$-5.7M
$38.6M
Q2 24
$-6.5M
$-4.3M
Free Cash Flow
EOLS
EOLS
TSSI
TSSI
Q1 26
Q4 25
$11.3M
$15.8M
Q3 25
$-15.6M
$-24.9M
Q2 25
$-25.5M
$5.4M
Q1 25
$-16.0M
$5.8M
Q4 24
$4.4M
$-28.4M
Q3 24
$-6.0M
$38.6M
Q2 24
$-6.9M
$-6.0M
FCF Margin
EOLS
EOLS
TSSI
TSSI
Q1 26
Q4 25
12.6%
25.9%
Q3 25
-22.7%
-59.3%
Q2 25
-36.7%
12.3%
Q1 25
-23.3%
5.8%
Q4 24
5.5%
-56.7%
Q3 24
-9.9%
55.1%
Q2 24
-10.4%
-49.4%
Capex Intensity
EOLS
EOLS
TSSI
TSSI
Q1 26
Q4 25
1.6%
0.9%
Q3 25
1.4%
15.3%
Q2 25
1.0%
24.8%
Q1 25
0.5%
15.0%
Q4 24
0.6%
13.4%
Q3 24
0.5%
0.1%
Q2 24
0.7%
13.8%
Cash Conversion
EOLS
EOLS
TSSI
TSSI
Q1 26
Q4 25
98.67×
1.34×
Q3 25
Q2 25
11.02×
Q1 25
6.93×
Q4 24
-11.32×
Q3 24
14.60×
Q2 24
-3.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EOLS
EOLS

Product revenue, net$72.7M99%
Service revenue$390.0K1%

TSSI
TSSI

Procurement Revenues Segment$43.2M71%
System Integration Services Segment$14.2M23%
Facilities Segment$3.5M6%

Related Comparisons